The Efficacy And Safety Profile Of Ixazomib-Based Regimens In Patients With Relapsed/Refractory Multiple Myeloma In Routine Clinical Practice: Real World Data From A Multi-Center Study In China
BLOOD（2019）
摘要
J Li, L Bao, ZJ Xia and KY Ding contributed equally to this study.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要